INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY

被引：0
|
作者：
Minard-Colin, V.
Auperin, A.
Burke, A.
Alexander, S.
Moreno, M.
Buffardi, S.
Uyttebroeck, A.
Bollard, C.
Zsiros, J.
Csoka, M.
Kazanowska, B.
Chiang, A.
Verschuur, A.
Miles, R.
Wotherspoon, A.
Barkauskas, D.
Wheatley, K.
Vassal, G.
Adamson, P.
Gross, T.
Patte, C.
Pillon, M.
机构：
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
061
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [31] Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)
    Hochberg, Jessica C.
    Goldman, Stanton
    Barth, Matthew J.
    Shi, Qiuhu
    Klejmont, Liana
    Harrison, Lauren
    Basso, Jackie
    Chu, Yaya
    Islam, Humayun
    Gerard, Perry
    Oesterheld, Javier
    Heym, Kenneth Matthew
    Kirov, Ivan I.
    Drachtman, Richard A.
    Harker-Murray, Paul
    Perkins, Sherrie L.
    Miles, Rodney R.
    Shiramizu, Bruce
    Cairo, Mitchell S.
    BLOOD, 2020, 136
  • [32] Safety, kinetics, and outcome following rituximab (R) in combination with FAB chemotherapy in children and adolescents (C plus A) with stage III/IV (Group B) and BM plus /CNS plus (Group C) mature B-NHL: A Children's Oncology Group report.
    Cairo, M. S.
    Lynch, J. C.
    Harrison, L.
    Perkins, S. L.
    Shiramizu, B.
    Gross, T. G.
    Sanger, W.
    Goldman, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Low level of cerebrospinal fluid (CSF) rituximab (RTX) following intravenous rituximab in children, adolescents and young adults (CAYA) with de novo mature B-cell Non-Hodgkin lymphoma (B-NHL)
    Barth, Matthew J.
    Chu, Yaya
    Goldman, Stanton C.
    Hochberg, Jessica
    Oesterheld, Javier
    Heym, Kenneth
    Harrison, Lauren
    Mahanti, Harshini
    Flowers, Allyson
    Basso, Jackie
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 47 - 47
  • [34] Rituximab and reduced-intensity chemotherapy in children and adolescents with mature B-cell lymphoma: interim results for 231 patients enrolled in the second Russian-Belorussian multicentre study B-NHL-2010M
    Maschan, Alexey
    Myakova, Natalia
    Aleinikova, Olga
    Abugova, Yulia
    Ponomareva, Natalia
    Belogurova, Margarita
    Fechina, Larisa
    Fedorova, Alina
    Grigor'eva, Natalia
    Lebedev, Vladimir
    Nikonova, Olga
    Shamardina, Anastassia
    Sharapova, Guzel
    Smirnova, Nadezhda
    Rudneva, Anastassia
    Volchkov, Egor
    Samochatova, Elena
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (03) : 477 - 483
  • [35] High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BONE MARROW TRANSPLANTATION, 2005, 35 : S385 - S385
  • [36] The role of 18F-FDG-PET/CT for early response evaluation in pediatric high-grade B-cell lymphoma patients treated with the inter-B-NHL ritux 2010 protocol
    Berger-Achituv, Sivan
    Bella, Bielorai
    Hanna, Golan
    Lerman, Hedva
    Even-Sapir, Einat
    Rosenfeld-Keidar, Hila
    Dvir, Rina
    Levin, Dror
    Amos, Toren
    Elhasid, Ronit
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 69 - 70
  • [37] Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial
    Goy, Andre
    Leach, Joseph
    Ehmann, Christopher
    Ando, Kiyoshi
    Hatake, Kiyohiko
    Tobinai, Kensei
    Feldiman, Tatyana
    Hua, Steven
    Volkert, Angela D. G.
    Vandendries, Erik R.
    Ogura, Michinori
    BLOOD, 2010, 116 (21) : 192 - 193
  • [38] MINIMAL DISSEMINATED DISEASE/RESIDUAL DISEASE IN CHILDREN AND ADOLESCENTS WITH MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL) MAY IMPACT THE RISK OF RELAPSE: A CHILDREN'S ONCOLOGY GROUP REPORT
    Shiramizu, B.
    Goldman, S.
    Smith, L.
    Harrison, L.
    Van De Ven, C.
    Gross, T. G.
    Sanger, W.
    Perkins, S.
    Cairo, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 : 114 - 114
  • [39] A prospective trial of prophylaxis and treatment (P plus T) of acute tumor lysis syndrome (ATLS) with rasburicase (R) and nonalkaline hydration in children and adolescents (C plus A) with intermediate- (Group B) and high-risk (Group C) mature B-NHL: A Children's Oncology Group report
    Goldman, S.
    Lynch, J. C.
    Harrison, L.
    Cairo, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Deletion of cranial irradiation and addition of systemic high dose methotrexate and intrathecal chemotherapy results in 70% 4-yr. EFS in children and adolescents with CNS positive B-NHL: Results of International FAB/LMB 96 study
    Cairo, M
    Gerrard, M
    Sposto, R
    Auperin, A
    Pinkerton, R
    Michon, J
    Weston, C
    Perkins, S
    Raphael, M
    McCarthy, K
    Patte, C
    ANNALS OF ONCOLOGY, 2005, 16 : 62 - 62
12345